Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clonal Hematopoiesis of Indeterminate Potential and Residual Cardiovascular Event Tendency After Smoking Cessation

NCT04987268 is registered in ClinicalTrials.gov with Shenyang Northern Hospital as lead sponsor.

NCT NCT04987268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04987268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clonal Hematopoiesis of Indeterminate Potential and Residual Cardiovascular Event Tendency After Smoking Cessation
Lead sponsor
Shenyang Northern Hospital
Phase
Observational
Overall status
Completed
Start date
August 20, 2021
Completion date
August 20, 2023
Enrollment
1,029 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acs, clonal hematopoiesis of indeterminate potential, smoking cessation